End of AIDS pandemic in sight: US expert

July 18, 2012 by Jean-Louis Santini

Three decades into the AIDS pandemic an end to new infections is in sight, according to Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases.

"We don't even know if a cure is possible. What we know is it is possible that we can end this pandemic even without a cure," Fauci told AFP in an interview ahead of the International AIDS conference July 22-27 in the US capital.

Some 34 million people around the world are living with , which has killed 25 million since it first emerged in the 1980s.

The theme of this conference, held every two years, is "Turning the Tide Together," and is based on experts sharing knowledge of the latest advances and how to best implement them in order to halt new cases of /AIDS.

"We have good and effective treatments but we have to keep people on the treatments indefinitely in order to keep them well," said Fauci, referring to which have transformed a into a manageable condition.

"When you have a very marked diminution of the number of new infections then you reach what we call and AIDS-free generation."

Fauci said he did not expect any staggering breakthroughs to be announced at the conference, but that the gain would come though collaborating on ideas to speed progress by using the tools that practitioners have already at hand.

Otherwise, if progress continues at the present rate of reducing new infections worldwide by about 1.5 percent per year, the goal becomes too distant, he said.

Recent studies that tested antiretroviral drugs in healthy people as a way to prevent getting HIV through sex with infected partners have shown some promise, though getting people to take their medication daily had proven a challenge.

"The important thing is you have to take your medication," Fauci said, noting that average HIV risk reduction in a study of men who have sex with men was just 44 percent.

The approach of treating healthy people with antiretrovirals is known as pre-exposure prophylaxis, and "is not for everyone," Fauci said. "We have to selectively use it."

The US Food and Drug Administration on Monday approved the first pill for HIV prevention, Truvada, despite concerns by some in the health care community that it could encourage drug resistance and risky sex.

Novel ways to boost testing are also good news, particularly with the recent US approval of the first at-home HIV test.

"It is so important in the quest to ending the AIDS pandemic to get as many people tested as possible. You can link them to care and get them on treatment. Anything that makes that goal easier would be an important advance."

As far as an AIDS vaccine, Fauci said researchers have made "good progress" but "still have a long way to go."

Experts are examining a trial done in Thailand that showed in 2009 modest efficacy of just over 30 percent, but is still considered a breakthrough and offers clues for future study into why some were helped and others were not.

Fauci also said he did not expect much concern to be raised over upcoming reports of the extent of drug resistance to antiretrovirals.

"People may think I am taking it lightly but quite frankly it is not a serious problem," Fauci said.

He added that overall, AIDS research is "going well" even though "funding is restricted right now."

And he expressed pride in the ' President's Emergency Plan for AIDS Relief (PEPFAR), "which has really transformed how you can get people in low income countries to get on treatment care and prevention."

The United States provides almost half the world's funding for international HIV assistance, according to UNAIDS.

The International AIDS Conference is returning to the United States after more than two decades away due to a ban on travel and immigration by people with HIV that was lifted in 2008 and signed into law in 2009.

Fauci called those restrictive laws "unfortunate" and "embarrassing."

Explore further: Key goals for building on 30 years of HIV/AIDS research

Related Stories

Key goals for building on 30 years of HIV/AIDS research

May 31, 2011
In the 30 years since the first reported cases of a mysterious illness now known as AIDS, researchers have made extraordinary advances in understanding, treating and preventing the disease. Now the challenge, according to ...

Hopes high as AIDS conference returns to US

July 15, 2012
A cure for AIDS remains a distant prospect but a host of drug treatments and other advances have fueled fresh hope that new human immunodeficiency virus infections may some day be halted for good.

Major AIDS forum gets down to work amid surge of good news

July 17, 2011
A global medical forum on AIDS got down to business on Sunday for four days of debate on powerful new weapons to combat a pandemic that in 30 years has claimed as many lives as a World War.

Recommended for you

Three-in-one antibody protects monkeys from HIV-like virus

September 20, 2017
A three-pronged antibody made in the laboratory protected monkeys from infection with two strains of SHIV, a monkey form of HIV, better than individual natural antibodies from which the engineered antibody is derived, researchers ...

Fighting HIV on multiple fronts might lead to vaccine

September 20, 2017
A combination antibody strategy could be the key to halting the spread of HIV, according to results from two promising animal studies.

HIV-AIDS: Following your gut

September 18, 2017
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have discovered a way to slow viral replication in the gastrointestinal tract of people infected by HIV-AIDS.

Study finds cutbacks in foreign aid for HIV treatment would cause great harm

August 30, 2017
Proposed reductions in U.S. foreign aid would have a devastating impact on HIV treatment and prevention programs in countries receiving such aid, an international team of investigators reports. In their paper published online ...

Cancer drug can reactivate HIV

August 24, 2017
People living with HIV must take a combination of three or more different drugs every day for the rest of their lives. Unfortunately, by following this strict treatment plan, they can suffer from side effects ranging from ...

New injectable antiretroviral treatment proved to be as effective as standard oral therapy

August 3, 2017
Intramuscularly administered antiretroviral therapy (ART) may be as effective for HIV treatment as current oral therapies. This is the main conclusion of a Phase II clinical trial carried out by 50 research centers around ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.